Population Pharmacokinetics of Cycloserine and Pharmacokinetic/Pharmacodynamic Target Attainment in Multidrug-Resistant Tuberculosis Patients Dosed with Terizidone

Cycloserine is a WHO group B drug for the treatment of multidrug-resistant tuberculosis (TB). Pharmacokinetic/pharmacodynamic data for cycloserine when dosed as terizidone are sparse. The aim of this analysis was to describe the population pharmacokinetics of cycloserine when administered as terizid...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Chirehwa, Maxwell T., Court, Richard, de Kock, Mariana, Wiesner, Lubbe, de Vries, Nihal, Harding, Joseph, Gumbo, Tawanda, Maartens, Gary, Warren, Rob, Denti, Paolo, McIlleron, Helen
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2020
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7577169/
https://ncbi.nlm.nih.gov/pubmed/32816738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01381-20
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados